Kevin Winthrop, MD, MPH

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant
    Ineligible company: 
    Insmed
    Topic: 
    NTM
  • Attribution: 
    Self
    Type of financial relationship: 
    Research Funding (if you were the principal or named investigator)
    Ineligible company: 
    Insmed
    Topic: 
    NTM research
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant
    Ineligible company: 
    RedHill Biopharma
    Topic: 
    NTM
  • Attribution: 
    Self
    Type of financial relationship: 
    Research Funding (if you were the principal or named investigator)
    Ineligible company: 
    RedHill Biopharma
    Topic: 
    NTM research
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant
    Ineligible company: 
    Spero
    Topic: 
    NTM
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant
    Ineligible company: 
    AN2 Therapeutics
    Topic: 
    NTM
    Date added: 
    02/07/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Research Funding (if you were the principal or named investigator)
    Ineligible company: 
    AN2 Therapeutics
    Topic: 
    NTM research
    Date added: 
    02/07/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant
    Ineligible company: 
    Paratek
    Topic: 
    NTM
    Date added: 
    02/07/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Research Funding (if you were the principal or named investigator)
    Ineligible company: 
    Paratek
    Topic: 
    NTM research
    Date added: 
    02/07/2022
Return to 2022 Infectious Disease Board Review Course